ATP citrate-lyase

CAT # Product Name Tsanangudzo
CPD3611 SB-204990 SB-204990 ndiyo prodrug yeakasimba ATP citrate-lyase inhibitor SB-201076. SB-204990, painopihwa nemuromo kumakonzo, yakanyudzwa mukati me systemic kutenderera, pharmacologically yakakosha kutariswa kweSB-201076 yakadzoserwa muchiropa. SB-204990 (25 mg/kg pazuva) zvakare yakaderedza plasma cholesterol mazinga (kusvika kusvika 23%) uye triglyceride mazinga (kusvika kusvika 38%) mumbwa, zvichinyanya kuderera pasi-density lipoprotein kana ichienzaniswa nepamusoro-density lipoprotein cholesterol. mazinga. SB-204990 inzyme yakakosha mukudzora substrate kupihwa kwelipid synthesis de novo uye inogona kuita enzyme tarisiro yekupindira kwe hypolipidemic.
...

Taura nesu

Inquiry

Latest News

  • Pamusoro 7 Trends MuKutsvaga Kwemishonga Muna 2018

    Epamusoro 7 Mafambiro Mukutsvakurudza Kwemishonga Ini...

    Kuve pasi pekumanikidzwa kunoramba kuchiwedzera kukwikwidza munzvimbo yakaoma yehupfumi uye tekinoroji, makambani emishonga uye ebiotech anofanirwa kuramba achivandudza muzvirongwa zvavo zveR&D kuti varambe vari mberi ...

  • ARS-1620: Inovimbisa inhibitor itsva yeKRAS-mutant cancers

    ARS-1620: Inhibitor itsva inovimbisa yeK...

    Zvinoenderana neongororo yakaburitswa muSero, vaongorori vakagadzira chaiyo inhibitor yeKRASG12C inonzi ARS-1602 iyo yakakonzera kudzoka kwebundu mumakonzo. "Chidzidzo ichi chinopa in vivo humbowo hwekuti mutant KRAS inogona ...

  • AstraZeneca inogamuchira kukwidziridzwa kwemishonga yeoncology

    AstraZeneca inogamuchira kukwidziridzwa kwe ...

    AstraZeneca yakagamuchira kukwidziridzwa kwakapetwa kaviri kweiyo oncology portfolio neChipiri, mushure mekunge US neEuropean regulators vabvuma kutumirwa kwemishonga yavo, danho rekutanga rekuhwina mvumo yemishonga iyi. ...

WhatsApp Online Chat !